Sage Therapeutics, Inc. Depreciation in USD from 2013 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sage Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2013 to Q1 2025.
  • Sage Therapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $112K, a 66.7% decline year-over-year.
  • Sage Therapeutics, Inc. annual Depreciation for 2024 was $1.03M, a 26% decline from 2023.
  • Sage Therapeutics, Inc. annual Depreciation for 2023 was $1.39M, a 24.2% increase from 2022.
  • Sage Therapeutics, Inc. annual Depreciation for 2022 was $1.12M, a 73.2% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Sage Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $112K -$224K -66.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-29
Q1 2024 $336K +$13K +4.03% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-29
Q1 2023 $323K +$48K +17.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q1 2022 $1.88M $275K -$2.31M -89.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $4.18M $300K -$261K -46.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $4.44M $400K -$300K -42.9% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $4.74M $900K +$200K +28.6% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $4.54M $2.58M +$1.91M +286% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $2.63M $561K -$107K -16% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $2.74M $700K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $2.74M $700K +$200K +40% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $2.54M $669K +$254K +61.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $2.28M $668K +$272K +68.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $2.01M $700K +$400K +133% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.61M $500K +$300K +150% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.31M $415K +$168K +68% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.14M $396K Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $300K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $200K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $247K +$117K +90% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2017 $130K +$89K +217% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q1 2016 $41K +$19K +86.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $22K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06

Sage Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.03M -$362K -26% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-11
2023 $1.39M +$271K +24.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-11
2022 $1.12M -$3.06M -73.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-11
2021 $4.18M +$1.55M +59% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
2020 $2.63M +$347K +15.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $2.28M +$1.14M +99.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $1.14M +$612K +115% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $531K +$250K +89% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $281K +$166K +144% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
2015 $115K +$64K +125% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $51K +$4K +8.51% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-24
2013 $47K Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.